A peptide blend is two or more research compounds co-lyophilized into a single vial, designed for combination research protocols where the components are typically studied together. Blends simplify combination work by ensuring a fixed dose ratio and unified COA.
Why Blends Exist
Some research protocols routinely combine specific compounds — for example:
- BPC-157 + TB-500 for tissue research
- CJC-1295 + Ipamorelin for growth axis research
- BPC-157 + TB-500 + GHK-Cu for multi-pathway tissue research
A blend supplies these in pre-mixed form, eliminating the need to draw two or three separate vials and ensuring the ratio is consistent batch-to-batch.
QC for Blends
A research-grade blend COA reports:
- Total mass per vial
- Per-component mass (e.g., “10mg BPC-157 + 10mg TB-500” in a 20mg blend)
- HPLC purity for each component identified separately in the chromatogram
- Endotoxin result for the blend as a unit
Matte’s Available Blends
- BPC-157 / TB-500 Blend 20mg
- CJC-1295 / Ipamorelin Blend 10mg
- Tesamorelin / Ipamorelin Blend 15mg
- GLOW Blend 70mg (BPC + TB + GHK)
- KLOW Blend 80mg (KPV + BPC + TB + GHK)
Research use only. Not for human consumption. Statements not evaluated by the US FDA.